IL-16 induces intestinal inflammation via PepT1 upregulation in a pufferfish model: New insights into the molecular mechanism of inflammatory bowel disease

Journal of Immunology

Volumn 191, Issue 3, 2013, Pages 1413-1427

  Wang, Ping ^a,b,c   Lu, Yi Qi ^a,b,c   Wen, Yi ^a,b,c   Yu, Dai Yong ^a,b,c   Ge, Liang ^a,b,c   Dong, Wei Ren ^a,b,c   Xiang, Li Xin ^a,b,c   Shao, Jian Zhong ^a,b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b Key Laboratory for Cell and Gene Engineering of Zhejiang Province   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 16; MYELOPEROXIDASE; PEPTIDE TRANSPORTER 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLON; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUFFER FISH; TETRAODON NIGROVIRIDIS; ULCERATIVE COLITIS; UPREGULATION;

ANIMALS; ANTIBODIES; CELL LINE, TUMOR; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HELA CELLS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-16; INTESTINAL MUCOSA; INTESTINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SYMPORTERS; TETRAODONTIFORMES; UP-REGULATION;

EID: 84880692710     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202598     Document Type: Article

References (76)

1. Xavier, R. J., and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Kaser, A., S. Zeissig, and R. S. Blumberg. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28: 573-621.
3. Khor, B., A. Gardet, and R. J. Xavier. 2011. Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307-317.
4. Siegmund, B., and M. Zeitz. 2011. Innate and adaptive immunity in inflammatory bowel disease. World J. Gastroenterol. 17: 3178-3183.
5. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
6. Hampe, J., A. Franke, P. Rosenstiel, A. Till, M. Teuber, K. Huse, M. Albrecht, G. Mayr, F. M. De La Vega, J. Briggs, et al. 2007. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39: 207-211.
7. Peltekova, V. D., R. F. Wintle, L. A. Rubin, C. I. Amos, Q. Huang, X. Gu, B. Newman, M. Van Oene, D. Cescon, G. Greenberg, et al. 2004. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat. Genet. 36: 471-475.
8. Rioux, J. D., M. J. Daly, M. S. Silverberg, K. Lindblad, H. Steinhart, Z. Cohen, T. Delmonte, K. Kocher, K. Miller, S. Guschwan, et al. 2001. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29: 223-228.
9. Rioux, J. D., R. J. Xavier, K. D. Taylor, M. S. Silverberg, P. Goyette, A. Huett, T. Green, P. Kuballa, M. M. Barmada, L. W. Datta, et al. 2007. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39: 596-604.
10. Xiao, H., M. F. Gulen, J. Qin, J. Yao, K. Bulek, D. Kish, C. Z. Altuntas, D. Wald, C. Ma, H. Zhou, et al. 2007. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26: 461-475.
11. Piao, J. H., M. Hasegawa, B. Heissig, K. Hattori, K. Takeda, Y. Iwakura, K. Okumura, N. Inohara, and H. Nakano. 2011. Tumor necrosis factor receptorassociated factor (TRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease. J. Biol. Chem. 286: 17879-17888.
12. Swidsinski, A., A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, M. Ortner, J. Weber, U. Hoffmann, S. Schreiber, M. Dietel, and H. Lochs. 2002. Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
13. Petnicki-Ocwieja, T., T. Hrncir, Y. J. Liu, A. Biswas, T. Hudcovic, H. Tlaskalova-Hogenova, and K. S. Kobayashi. 2009. Nod2 is required for the regulation of commensal microbiota in the intestine. Proc. Natl. Acad. Sci. USA 106: 15813-15818.
14. Liu, Z., and M. J. Lenardo. 2012. The role of LRRK2 in inflammatory bowel disease. Cell Res. 22: 1092-1094.
15. Bamias, G., M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli. 2006. Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proc. Natl. Acad. Sci. USA 103: 8441-8446.
16. Takedatsu, H., K. S. Michelsen, B. Wei, C. J. Landers, L. S. Thomas, D. Dhall, J. Braun, and S. R. Targan. 2008. TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology 135: 552-567.
17. Rogler, G., and T. Andus. 1998. Cytokines in inflammatory bowel disease. World J. Surg. 22: 382-389.
18. Danese, S. 2012. New therapies for inflammatory bowel disease: from the bench to the bedside. Gut 61: 918-932.
19. Seegert, D., P. Rosenstiel, H. Pfahler, P. Pfefferkorn, S. Nikolaus, and S. Schreiber. 2001. Increased expression of IL-16 in inflammatory bowel disease. Gut 48: 326-332.
20. Gao, L. B., L. Rao, Y. Y. Wang, W. B. Liang, C. Li, H. Xue, B. Zhou, H. Sun, Y. Li, M. L. Lv, et al. 2009. The association of interleukin-16 polymorphisms with IL-16 serum levels and risk of colorectal and gastric cancer. Carcinogenesis 30: 295-299.
21. Keates, A. C., I. Castagliuolo, W. W. Cruickshank, B. Qiu, K. O. Arseneau, W. Brazer, and C. P. Kelly. 2000. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice. Gastroenterology 119: 972-982.
22. Middel, P., K. Reich, F. Polzien, V. Blaschke, B. Hemmerlein, J. Herms, M. Korabiowska, and H. J. Radzun. 2001. Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease. Gut 49: 795-803.
23. Glas, J., H. P. Török, H. Unterhuber, M. Radlmayr, and C. Folwaczny. 2003. The 2295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease. Clin. Immunol. 106: 197-200.
24. Cruikshank, W., and D. M. Center. 1982. Modulation of lymphocyte migration by human lymphokines. II. Purification of a lymphotactic factor (LCF). J. Immunol. 128: 2569-2574.
25. Center, D. M., and W. Cruikshank. 1982. Modulation of lymphocyte migration by human lymphokines. I. Identification and characterization of chemoattractant activity for lymphocytes from mitogen-stimulated mononuclear cells. J. Immunol. 128: 2563-2568.
26. Glass, W. G., R. T. Sarisky, and A. M. Vecchio. 2006. Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. J. Interferon Cytokine Res. 26: 511-520.
27. Mühlhahn, P., M. Zweckstetter, J. Georgescu, C. Ciosto, C. Renner, M. Lanzendörfer, K. Lang, D. Ambrosius, M. Baier, R. Kurth, and T. A. Holak. 1998. Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site. Nat. Struct. Biol. 5: 682-686.
28. Burge, C., and S. Karlin. 1997. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268: 78-94.
29. Wen, Y., J. Z. Shao, L. X. Xiang, and W. Fang. 2006. Cloning, characterization and expression analysis of two Tetraodon nigroviridis interleukin-16 isoform genes. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 144: 159-166.
30. Schultz, J., F. Milpetz, P. Bork, and C. P. Ponting. 1998. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl. Acad. Sci. USA 95: 5857-5864.
31. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22: 4673-4680.
32. Kumar, S., K. Tamura, and M. Nei. 2004. MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief. Bioinform. 5: 150-163.
33. Saitou, N., and M. Nei. 1987. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4: 406-425.
34. Hu, Y. X., J. Y. Guo, L. Shen, Y. Chen, Z. C. Zhang, and Y. L. Zhang. 2002. Get effective polyclonal antisera in one month. Cell Res. 12: 157-160.
35. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 22DDC(T) method. Methods 25: 402-408.
36. Wirtz, S., C. Neufert, B. Weigmann, and M. F. Neurath. 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2: 541-546.
37. Krawisz, J. E., P. Sharon, and W. F. Stenson. 1984. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350.
38. Liutkeviciute, Z., G. Lukinavicius, V. Masevicius, D. Daujotyte, and S. Klimasauskas. 2009. Cytosine-5-methyltransferases add aldehydes to DNA. Nat. Chem. Biol. 5: 400-402.
39. Elbashir, S. M., J. Harborth, K. Weber, and T. Tuschl. 2002. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213.
40. Lee, J. H., E. S. Cho, M. Y. Kim, Y. W. Seo, D. H. Kho, I. J. Chung, H. Kook, N. S. Kim, K. Y. Ahn, and K. K. Kim. 2005. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein. Cancer Res. 65: 8993-9003.
41. Wirtz, S., and M. F. Neurath. 2007. Mouse models of inflammatory bowel disease. Adv. Drug Deliv. Rev. 59: 1073-1083.
42. Kim, J. J., M. S. Shajib, M. M. Manocha, and W. I. Khan. 2012. Investigating intestinal inflammation in DSS-induced model of IBD. J. Vis. Exp. 60: 3678.
43. Fang, K., M. Bruce, C. B. Pattillo, S. Zhang, R. Stone, II, J. Clifford, and C. G. Kevil. 2011. Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis. Physiol. Genomics 43: 43-56.
44. Yan, Y., V. Kolachala, G. Dalmasso, H. Nguyen, H. Laroui, S. V. Sitaraman, and D. Merlin. 2009. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE 4: e6073.
45. Okayasu, I., S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki, and R. Nakaya. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.
46. Arnhold, J., and J. Flemmig. 2010. Human myeloperoxidase in innate and acquired immunity. Arch. Biochem. Biophys. 500: 92-106.
47. van der Veen, B. S., M. P. de Winther, and P. Heeringa. 2009. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signal. 11: 2899-2937.
48. Oehlers, S. H., M. V. Flores, C. J. Hall, S. Swift, K. E. Crosier, and P. S. Crosier. 2011. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish. Dis. Model. Mech. 4: 832-841.
49. Love, D. R., C. C. Lan, A. Dodd, A. N. Shelling, W. C. McNabb, and L. R. Ferguson. 2007. Modeling inflammatory bowel disease: the zebrafish as a way forward. Expert Rev. Mol. Diagn. 7: 177-193.
50. Oehlers, S. H., M. V. Flores, K. S. Okuda, C. J. Hall, K. E. Crosier, and P. S. Crosier. 2011. A chemical enterocolitis model in zebrafish larvae that is dependent on microbiota and responsive to pharmacological agents. Dev. Dyn. 240: 288-298.
51. Buyse, M., A. Tsocas, F. Walker, D. Merlin, and A. Bado. 2002. PepT1-mediated fMLP transport induces intestinal inflammation in vivo. Am. J. Physiol. Cell Physiol. 283: C1795-C1800.
52. Daniel, H., B. Spanier, G. Kottra, and D. Weitz. 2006. From bacteria to man: archaic proton-dependent peptide transporters at work. Physiology (Bethesda) 21: 93-102.
53. Daniel, H., and G. Kottra. 2004. The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflugers Arch. 447: 610-618.
54. Wolf, J. C., and M. J. Wolfe. 2003. Good laboratory practice considerations in the use of fish models. Toxicol. Pathol. 31(Suppl): 53-57.
55. Lieschke, G. J., and P. D. Currie. 2007. Animal models of human disease: zebrafish swim into view. Nat. Rev. Genet. 8: 353-367.
56. Roest Crollius, H., O. Jaillon, A. Bernot, C. Dasilva, L. Bouneau, C. Fischer, C. Fizames, P. Wincker, P. Brottier, F. Quétier, et al. 2000. Estimate of human gene number provided by genome-wide analysis using Tetraodon nigroviridis DNA sequence. Nat. Genet. 25: 235-238.
57. Roest Crollius, H., O. Jaillon, C. Dasilva, C. Ozouf-Costaz, C. Fizames, C. Fischer, L. Bouneau, A. Billault, F. Quetier, W. Saurin, et al. 2000. Characterization and repeat analysis of the compact genome of the freshwater pufferfish Tetraodon nigroviridis. Genome Res. 10: 939-949.
58. Walter, R. B. 2001. Introduction: aquaria fish models of human disease. Mar. Biotechnol. (NY) 3(Suppl. 1): S1-S2.
59. Bahary, N., and L. I. Zon. 1998. Use of the zebrafish (Danio rerio) to define hematopoiesis. Stem Cells 16: 89-98.
60. Bui, P., M. Bagherie-Lachidan, and S. P. Kelly. 2010. Cortisol differentially alters claudin isoforms in cultured puffer fish gill epithelia. Mol. Cell. Endocrinol. 317: 120-126.
61. Clelland, E. S., P. Bui, M. Bagherie-Lachidan, and S. P. Kelly. 2010. Spatial and salinity-induced alterations in claudin-3 isoform mRNA along the gastrointestinal tract of the pufferfish Tetraodon nigroviridis. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 155: 154-163.
62. Drummond, I. A., A. Majumdar, H. Hentschel, M. Elger, L. Solnica-Krezel, A. F. Schier, S. C. Neuhauss, D. L. Stemple, F. Zwartkruis, Z. Rangini, et al. 1998. Early development of the zebrafish pronephros and analysis of mutations affecting pronephric function. Development 125: 4655-4667.
63. Feitsma, H., and E. Cuppen. 2008. Zebrafish as a cancer model. Mol. Cancer Res. 6: 685-694.
64. Ingham, P. W. 2009. The power of the zebrafish for disease analysis. Hum. Mol. Genet. 18(R1): R107-R112.
65. Sepulcre, M. P., F. Alcaraz-Pérez, A. López-Munoz, F. J. Roca, J. Meseguer, M. L. Cayuela, and V. Mulero. 2009. Evolution of lipopolysaccharide (LPS) recognition and signaling: fish TLR4 does not recognize LPS and negatively regulates NF-kB activation. J. Immunol. 182: 1836-1845.
66. Weinstein, B. M., A. F. Schier, S. Abdelilah, J. Malicki, L. Solnica-Krezel, D. L. Stemple, D. Y. Stainier, F. Zwartkruis, W. Driever, and M. C. Fishman. 1996. Hematopoietic mutations in the zebrafish. Development 123: 303-309.
67. Marasco, W. A., S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker, and P. A. Ward. 1984. Purification and identification of formylmethionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J. Biol. Chem. 259: 5430-5439.
68. Chadwick, V. S., D. M. Mellor, D. B. Myers, A. C. Selden, A. Keshavarzian, M. F. Broom, and C. H. Hobson. 1988. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand. J. Gastroenterol. 23: 121-128.
69. Adibi, S. A. 2003. Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. Am. J. Physiol. Gastrointest. Liver Physiol. 285: G779-G788.
70. Ingersoll, S. A., S. Ayyadurai, M. A. Charania, H. Laroui, Y. Yan, and D. Merlin. 2012. The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease. Am. J. Physiol. Gastrointest. Liver Physiol. 302: G484-G492.
71. Liang, R., Y. J. Fei, P. D. Prasad, S. Ramamoorthy, H. Han, T. L. Yang-Feng, M. A. Hediger, V. Ganapathy, and F. H. Leibach. 1995. Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization. J. Biol. Chem. 270: 6456-6463.
72. Shi, B., D. Song, H. Xue, N. Li, and J. Li. 2006. PepT1 mediates colon damage by transporting fMLP in rats with bowel resection. J. Surg. Res. 136: 38-44.
73. Ogihara, H., H. Saito, B. C. Shin, T. Terado, S. Takenoshita, Y. Nagamachi, K. Inui, and K. Takata. 1996. Immuno-localization of H+/peptide cotransporter in rat digestive tract. Biochem. Biophys. Res. Commun. 220: 848-852.
74. Merlin, D., M. Si-Tahar, S. V. Sitaraman, K. Eastburn, I. Williams, X. Liu, M. A. Hediger, and J. L. Madara. 2001. Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules. Gastroenterology 120: 1666-1679.
75. Wen, Y., W. Fang, L. X. Xiang, R. L. Pan, and J. Z. Shao. 2011. Identification of Treg-like cells in Tetraodon: insight into the origin of regulatory T subsets during early vertebrate evolution. Cell. Mol. Life Sci. 68: 2615-2626.
76. Steiner, H. Y., F. Naider, and J. M. Becker. 1995. The PTR family: a new group of peptide transporters. Mol. Microbiol. 16: 825-834.